期刊文献+

人血管生成素基因的克隆与表达 被引量:3

Cloning and Expression of Human Angiogenin Gene
下载PDF
导出
摘要 目的 为了获得人的血管生成素基因,并在原核表达系统中进行表达。方法 利用RT-PCR技术 从人的肝脏组织中扩增出Ang基因片段,并将其克隆到pGEM-T载体中进行序列分析,再亚克隆到原核表达到 pET28a(+)载体中。结果 构建了重组表达载体pETA,转化宿主菌BL21(DE3)后,经IPIG诱导,Ang基因蛋白在 BL21(DE3)中表达了相对分子质量约为17000的重组蛋白。SDS-PAGE和薄层扫描分析表明,外源蛋白的表达量 占菌体蛋白总量的10.64%。结论 Ang基因的克隆与表达为进一步研究其生物活性及应用奠定了基础。 Objective To obtain the gene of human angiogenin and express it in procaryotic expression system.Methods A fragment of human angiogenin (Ang) gene was amplified from liver tissue by RT- PCR, cloned into pGEM T vector and suquenced, then subcloned into procaryotic expression vector PET28a( + ) The recombinant plasmid pFTA was transformed to E . coli B121 (DE3) and expressed under the induction of IPTG. Results The recombinant protein with a molecular weight of about 17000 was expressed. SOS - PAGE and thin layer scanning proved that the expressed product contained 10.64%of the total somatic protein. Conclusion The study laid a foundation of further study on the biological activity and application of human angiogenin.
出处 《中国生物制品学杂志》 CAS CSCD 2001年第3期136-138,共3页 Chinese Journal of Biologicals
关键词 血管生成素 RT-PCR 克隆 表达 Angiogenin RT-PCR Cloning Expression
  • 相关文献

参考文献6

  • 1[1]Fett J W, Strydom D J, Lobb R R, et al. Isolation and characterization of Angiogenin, an Angiogenic protein from human carcinoma ceils . Biochemistry, 1985, 24: 5480-5486.
  • 2[2]Strydom D J, Fett J W, Lobb R R, et al. Amino acid sequence of human tumor derived Angiogenin . Biochernistry, 1985, 24: 5486-5494.
  • 3[3]Kuriachi K, Davie E W, Strydom D J, et al. Sequence of the cDNA and gene for Angiogenin, a human Angiogenesis factor. Biochemistry, 1985,24: 5494 - 5499.
  • 4[4]Sambrook J, Fritsch E F, Maniatis T, et al. Molecular cloning: A laboratory manual 2nd ed. New York: Cold Spring Habor Laboratory Press,1989, 24- 34.
  • 5[5]Folkman J. The role of Angiogenesis in tumor growth. Semin Cancer Biol, 1992, 3(2): 65 - 67.
  • 6[6]Rybak SM, Hoogenboom H R, Meade H M, et al. Humanization of immunotoxin. PNAS, 1992, 89: 3165-3169.

同被引文献12

  • 1ZEWE M, RYBAK S M, LITTLE M, et al. Cloning and cytotoxicity of a human pancreatic RNase immun ofusion[J]. Immunotechnology, 1997,32 : 127-136.
  • 2YOON J M,HAN S H,KOWN O B, et al. Cloning and cytotoxicity of fusion proteins of EGF and angiogenin[J]. Life Sci,1999,64:1435-1445.
  • 3HUHN M, SASSE S, TUR M K, et al. Human Angiogenin fused to human CD30 ligand (Ang-CD30L) exhibits specific cytotoxicity against CD30 positive lymphoma[J]. Cancer Res,2001,61:8737-8742.
  • 4Lelle R J, Talavera F, Gretz H, et al. Epidermal growth factor receptor expression in three different human endometrial cancer cell lines[J]. Cancer, 1993, 72(2): 519-525.
  • 5Osborne CK, Coronado-Heinsohn E. Targeting the epidermal growth factor receptor in breast cancer cell lines with a recombinant ligand fusion toxin[J]. Cancer J Sci Am, 1996, 2(3): 175-180.
  • 6Ako Kihara, Ira Pastan. Small chimeric toxins containing only transforming growth factor α and domain Ⅲ of Pseudomdnas Exotoxin with good antitumor activity in mice[ J]. Cancer Res, 1994,54 (5): 5154-5159.
  • 7Rybak SM, Hoogenboom HR, Meade HM, et al. Humanization of immunotoxin[J]. Proc Natl Acad Sci USA, 1992, 89: 3165-3169.
  • 8Fett JW, Strydom DJ, Lobb RR, et al. Isolation and characterization of angiogenin, an angiogenic proteinfrom human carcinoma cells[ J]. Biochemistry, 1985, 24: 5480-5486.
  • 9Zewe M, Rybak SM, Little M, et al. Cloning and cytotoxicity of a human pancreatic RNase immunofusion [ J ]. Immunotechnology,1997, 3(2): 127-136.
  • 10Huhn M, Sasse S, Tur MK, et al. Human angiogenin fused to human CD30 ligand (Ang-CD30L) exhibits specific cytotoxicity against CD30-positive lymphoma[ J]. Cancer Res, 2001,61 (24):8737-8742.

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部